Dr Reddy's Acquires MenoLabs Women's Health Brands
By Rediff Money Desk, HYDERABAD Jan 03, 2024 18:00
Dr Reddy's Laboratories acquires MenoLabs, a leading women's health and dietary supplement brand in the US, bolstering its self-care and wellness business.
![Dr Reddy's Acquires MenoLabs Women's Health Brands](https://im.rediff.com/money/2020/aug/19drug.jpg)
Hyderabad, Jan 3 (PTI) Dr Reddy's Laboratories Ltd on Wednesday said it has acquired the entire portfolio of MenoLabs, a leading women's health and dietary supplement brand, from Amyris Inc, a USA-based biotechnology company, through Chapter 11 of United States Bankruptcy Code.
A press release from the city-based drug maker said Dr Reddy's acquired the MenoLabs supplements portfolio which includes seven branded products designed to provide health support and address symptoms of perimenopause and menopause.
MenoLabs' portfolio of products is sold in the United States primarily through the brand's own e-commerce marketplace as well as through others including Amazon and Walmart.
The MenoLabs acquisition will serve as a catalyst to accelerate growth in this space and build upon our aspiration to lead in the fast-growing women's nutritional and wellness markets, Marc Kikuchi, Chief Executive Officer for Dr Reddy's in North America said.
The acquisition complements Dr Reddy's US's self-care and wellness business portfolio of brands and addresses unmet needs of consumers for science-based, research-driven products that provide relief from the symptoms of menopause, Kikuchi added.
A press release from the city-based drug maker said Dr Reddy's acquired the MenoLabs supplements portfolio which includes seven branded products designed to provide health support and address symptoms of perimenopause and menopause.
MenoLabs' portfolio of products is sold in the United States primarily through the brand's own e-commerce marketplace as well as through others including Amazon and Walmart.
The MenoLabs acquisition will serve as a catalyst to accelerate growth in this space and build upon our aspiration to lead in the fast-growing women's nutritional and wellness markets, Marc Kikuchi, Chief Executive Officer for Dr Reddy's in North America said.
The acquisition complements Dr Reddy's US's self-care and wellness business portfolio of brands and addresses unmet needs of consumers for science-based, research-driven products that provide relief from the symptoms of menopause, Kikuchi added.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- GTL Infrastructure
- 2.93 ( -4.87)
- 226206286
- IFL Enterprises
- 1.30 (+ 4.84)
- 81461564
- Vodafone Idea L
- 16.79 (+ 0.66)
- 67447398
- NCL Research
- 0.95 ( -4.04)
- 31996628
- Franklin Industries
- 3.73 (+ 3.32)
- 21511209
MORE NEWS
![Navi Mumbai...](https://im.rediff.com/80-80/money/2021/jun/10navi-mumbai-airport7.jpg)
Navi Mumbai Airport ILS Signal Testing Begins
The Airports Authority of India (AAI) has begun ILS signal testing at the...
![Air India VRS for...](https://im.rediff.com/80-80/money/2020/sep/09tata-vistara-3.jpg)
Air India VRS for Non-Flying Staff Ahead of...
Air India has announced a voluntary retirement scheme (VRS) and voluntary separation...
Fisher Groups Oppose WTO Fisheries Subsidy Talks
Small-scale fisher groups from India, Indonesia, and Bangladesh demand WTO keep...